Icon
+91 94997 68112
Login Register

VELETRI (nda022260)- (EQ 1.5MG BASE/VIAL,EQ 0.5MG BASE/VIAL)

EPOPROSTENOL SODIUM ACTELION
EQ 1.5MG BASE/VIAL,EQ 0.5MG BASE/VIAL
Yes Yes
2027-Mar-15 Expired
None None
None No
VELETRI is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity.
3 0 1
Total Other Developers 1
Drugs with Suitability No
EQ 1.5MG BASE/VIAL ** ** - - -
EQ 0.5MG BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** *** ***** *** ************** **********, ***. *********** ** ****** **, *********, ************* (**) *****, ****** ****** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.